Breifly, the type I IFN and IFN-γ signatures were significantly enhanced, accompanied by the transformation of healthy Monos into inflammatory Monos under the pre-teatment state, while the IFN responses recovered to control level in the post-treatment state, suggesting the effective reduction of inflammation in patients with JDM after treatment. Here, IFNA1 is linked to juvenile dermatomyositis.